337 related articles for article (PubMed ID: 11714894)
1. Interaction of the sulfonylthiourea HMR 1833 with sulfonylurea receptors and recombinant ATP-sensitive K(+) channels: comparison with glibenclamide.
Russ U; Lange U; Löffler-Walz C; Hambrock A; Quast U
J Pharmacol Exp Ther; 2001 Dec; 299(3):1049-55. PubMed ID: 11714894
[TBL] [Abstract][Full Text] [Related]
2. Interaction of a novel dihydropyridine K+ channel opener, A-312110, with recombinant sulphonylurea receptors and KATP channels: comparison with the cyanoguanidine P1075.
Felsch H; Lange U; Hambrock A; Löffler-Walz C; Russ U; Carroll WA; Gopalakrishnan M; Quast U
Br J Pharmacol; 2004 Apr; 141(7):1098-105. PubMed ID: 15023854
[TBL] [Abstract][Full Text] [Related]
3. Glibenclamide binding to sulphonylurea receptor subtypes: dependence on adenine nucleotides.
Hambrock A; Löffler-Walz C; Quast U
Br J Pharmacol; 2002 Aug; 136(7):995-1004. PubMed ID: 12145099
[TBL] [Abstract][Full Text] [Related]
4. Pharmacological comparison of native mitochondrial K(ATP) channels with molecularly defined surface K(ATP) channels.
Liu Y; Ren G; O'Rourke B; Marbán E; Seharaseyon J
Mol Pharmacol; 2001 Feb; 59(2):225-30. PubMed ID: 11160857
[TBL] [Abstract][Full Text] [Related]
5. Interaction of K(ATP) channel modulators with sulfonylurea receptor SUR2B: implication for tetramer formation and allosteric coupling of subunits.
Löffler-Walz C; Hambrock A; Quast U
Mol Pharmacol; 2002 Feb; 61(2):407-14. PubMed ID: 11809866
[TBL] [Abstract][Full Text] [Related]
6. Coexpression with the inward rectifier K(+) channel Kir6.1 increases the affinity of the vascular sulfonylurea receptor SUR2B for glibenclamide.
Russ U; Hambrock A; Artunc F; Löffler-Walz C; Horio Y; Kurachi Y; Quast U
Mol Pharmacol; 1999 Nov; 56(5):955-61. PubMed ID: 10531400
[TBL] [Abstract][Full Text] [Related]
7. Characterization of a mutant sulfonylurea receptor SUR2B with high affinity for sulfonylureas and openers: differences in the coupling to Kir6.x subtypes.
Hambrock A; Löffler-Walz C; Russ U; Lange U; Quast U
Mol Pharmacol; 2001 Jul; 60(1):190-9. PubMed ID: 11408614
[TBL] [Abstract][Full Text] [Related]
8. HMR 1098 is not an SUR isotype specific inhibitor of heterologous or sarcolemmal K ATP channels.
Zhang HX; Akrouh A; Kurata HT; Remedi MS; Lawton JS; Nichols CG
J Mol Cell Cardiol; 2011 Mar; 50(3):552-60. PubMed ID: 21185839
[TBL] [Abstract][Full Text] [Related]
9. Lipids modulate ligand binding to sulphonylurea receptors.
Klein A; Lichtenberg J; Stephan D; Quast U
Br J Pharmacol; 2005 Aug; 145(7):907-15. PubMed ID: 15895108
[TBL] [Abstract][Full Text] [Related]
10. The effects of mitiglinide (KAD-1229), a new anti-diabetic drug, on ATP-sensitive K+ channels and insulin secretion: comparison with the sulfonylureas and nateglinide.
Sunaga Y; Gonoi T; Shibasaki T; Ichikawa K; Kusama H; Yano H; Seino S
Eur J Pharmacol; 2001 Nov; 431(1):119-25. PubMed ID: 11716850
[TBL] [Abstract][Full Text] [Related]
11. The mutation Y1206S increases the affinity of the sulphonylurea receptor SUR2A for glibenclamide and enhances the effects of coexpression with Kir6.2.
Stephan D; Stauss E; Lange U; Felsch H; Löffler-Walz C; Hambrock A; Russ U; Quast U
Br J Pharmacol; 2005 Apr; 144(8):1078-88. PubMed ID: 15711591
[TBL] [Abstract][Full Text] [Related]
12. Molecular basis and characteristics of KATP channel in human corporal smooth muscle cells.
Insuk SO; Chae MR; Choi JW; Yang DK; Sim JH; Lee SW
Int J Impot Res; 2003 Aug; 15(4):258-66. PubMed ID: 12934053
[TBL] [Abstract][Full Text] [Related]
13. ATP-Sensitive K+ channel modulator binding to sulfonylurea receptors SUR2A and SUR2B: opposite effects of MgADP.
Hambrock A; Löffler-Walz C; Kloor D; Delabar U; Horio Y; Kurachi Y; Quast U
Mol Pharmacol; 1999 May; 55(5):832-40. PubMed ID: 10220561
[TBL] [Abstract][Full Text] [Related]
14. Tissue specificity of sulfonylureas: studies on cloned cardiac and beta-cell K(ATP) channels.
Gribble FM; Tucker SJ; Seino S; Ashcroft FM
Diabetes; 1998 Sep; 47(9):1412-8. PubMed ID: 9726229
[TBL] [Abstract][Full Text] [Related]
15. Effects of a novel cardioselective ATP-sensitive potassium channel antagonist, 1-[[5-[2-(5-chloro-o-anisamido)ethyl]-beta-methoxyethoxyphenyl]sulfonyl]-3-methylthiourea, sodium salt (HMR 1402), on susceptibility to ventricular fibrillation induced by myocardial ischemia: in vitro and in vivo studies.
Billman GE; Houle MS; Englert HC; Gögelein H
J Pharmacol Exp Ther; 2004 Apr; 309(1):182-92. PubMed ID: 14722326
[TBL] [Abstract][Full Text] [Related]
16. Stoichiometry of sulfonylurea-induced ATP-sensitive potassium channel closure.
Dörschner H; Brekardin E; Uhde I; Schwanstecher C; Schwanstecher M
Mol Pharmacol; 1999 Jun; 55(6):1060-6. PubMed ID: 10347249
[TBL] [Abstract][Full Text] [Related]
17. Potassium channel openers require ATP to bind to and act through sulfonylurea receptors.
Schwanstecher M; Sieverding C; Dörschner H; Gross I; Aguilar-Bryan L; Schwanstecher C; Bryan J
EMBO J; 1998 Oct; 17(19):5529-35. PubMed ID: 9755153
[TBL] [Abstract][Full Text] [Related]
18. Nateglinide, a D-phenylalanine derivative lacking either a sulfonylurea or benzamido moiety, specifically inhibits pancreatic beta-cell-type K(ATP) channels.
Chachin M; Yamada M; Fujita A; Matsuoka T; Matsushita K; Kurachi Y
J Pharmacol Exp Ther; 2003 Mar; 304(3):1025-32. PubMed ID: 12604678
[TBL] [Abstract][Full Text] [Related]
19. Cooperative binding of ATP and MgADP in the sulfonylurea receptor is modulated by glibenclamide.
Ueda K; Komine J; Matsuo M; Seino S; Amachi T
Proc Natl Acad Sci U S A; 1999 Feb; 96(4):1268-72. PubMed ID: 9990013
[TBL] [Abstract][Full Text] [Related]
20. Functional coupling between sulfonylurea receptor type 1 and a nonselective cation channel in reactive astrocytes from adult rat brain.
Chen M; Dong Y; Simard JM
J Neurosci; 2003 Sep; 23(24):8568-77. PubMed ID: 13679426
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
